• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

A cost-effectiveness analysis of over-the-counter statins.
CONCLUSIONS: With proper labeling and consumer education, it is highly likely that OTC statins would be cost-effective, as they significantly improve population health without large increases in healthcare costs. PMID: 27266585 [PubMed - in process]
Source: The American Journal of Managed Care - June 10, 2016 Category: Health Management Authors: Stomberg C, Albaugh M, Shiffman S, Sood N Tags: Am J Manag Care Source Type: research

Potential of risk-based population guidelines to reduce cardiovascular risk in a large integrated health system.
CONCLUSIONS: The risk calculator provided risk estimates in most patients and demonstrated fairly good discrimination and predictiveness. The risk-based decision tool identified high-risk patients for treatment not identified by traditional guidelines, as well as low-risk patients for whom treatment may be unnecessary. PMID: 27266582 [PubMed - in process]
Source: The American Journal of Managed Care - June 10, 2016 Category: Health Management Authors: Inzhakova G, Zhou H, Morris M, Early MI, Xiang AH, Jacobsen SJ, Derose SF Tags: Am J Manag Care Source Type: research

Do statins interfere with the flu vaccine?
Statins are powerful, unusual, and, like El Niño and Tom Cruise, not well understood. Statins have a huge upside. They improve survival after heart attacks and lower the risk of recurrent strokes. They are also the only cholesterol-lowering medications that have been clearly shown to reduce heart attacks and deaths in high-risk patients without heart disease. In addition to reducing cholesterol, statins also lower levels of inflammation in the body. Reducing inflammation probably helps statins to prevent heart attack and stroke. However, evidence is emerging that these statin effects may also have a downside, hindering th...
Source: New Harvard Health Information - November 30, 2015 Category: Consumer Health News Authors: John Ross, MD, FIDSA Tags: Cold and Flu Drugs and Supplements Health Heart Health Vaccines flu vaccine statins Source Type: news